---
title: "Konruns released its performance for the first three quarters, with a net profit attributable to the parent company of 128 million yuan, a year-on-year increase of 13.19%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263344297.md"
description: "According to the Zhitong Finance APP, Konruns disclosed its third-quarter report for 2025. The company achieved revenue of 692 million yuan in the first three quarters, a year-on-year increase of 7.10%; net profit attributable to the parent company was 128 million yuan, a year-on-year increase of 13.19%; net profit excluding non-recurring gains and losses was 133 million yuan, a year-on-year increase of 25.90%; basic earnings per share were 0.81 yuan"
datetime: "2025-10-29T16:44:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263344297.md)
  - [en](https://longbridge.com/en/news/263344297.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263344297.md)
---

# Konruns released its performance for the first three quarters, with a net profit attributable to the parent company of 128 million yuan, a year-on-year increase of 13.19%

According to the Zhitong Finance APP, Konruns (603590.SH) disclosed its third-quarter report for 2025, stating that the company achieved revenue of 692 million yuan in the first three quarters, a year-on-year increase of 7.10%; net profit attributable to shareholders was 128 million yuan, a year-on-year increase of 13.19%; net profit excluding non-recurring gains and losses was 133 million yuan, a year-on-year increase of 25.90%; basic earnings per share were 0.81 yuan

### Related Stocks

- [603590.CN](https://longbridge.com/en/quote/603590.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants | ANVS Stock News](https://longbridge.com/en/news/286960443.md)
- [NYC Health and Hospitals says hackers stole medical data and fingerprints during breach affecting at least 1.8 million people](https://longbridge.com/en/news/286799449.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)